Genmab — Marts 2018
-
-
God morgen.
-
@nohope, ja og under kæmpe volume igen
-
-
Vi har en øget short, pænt stort nettokøb fra A/B gruppen i længere tid, GMXAY medstor omsætning samt anbefalinger som stritter i hver sin retning (SHB, NSCB og Barclays). Det udfordrer hjerneceller at være aktionær i Genmab.
-
De er nogle gode bundfiskere.
-
Barclays summary
https://twitter.com/VikaTrader/status/969118545538899968 -
Er det ikke Danske som plejer at sælge aktier i forbindelse med warrants?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind